Harvest Investment Services, LLC Vir Biotechnology, Inc. Transaction History

Harvest Investment Services, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$34.9 - $54.54 $289,146 - $451,863	-8,285 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$38.75 - $51.0 $29,140 - $38,352	-752 Reduced 8.32%	8,285 $391,000
Q1 2021 May 06, 2021	SELL	$26.34 - $83.07 $353,798 - $1.12 Million	-13,432 Reduced 59.78%	9,037 $463,000
Q4 2020 Feb 01, 2021	BUY	$25.51 - $43.38 $46,938 - $79,819	1,840 Added 8.92%	22,469 $601,000
Q3 2020 Oct 29, 2020	BUY	$28.28 - $53.6 $202,965 - $384,687	7,177 Added 53.35%	20,629 $708,000
Q2 2020 Aug 11, 2020	BUY	$27.89 - $47.86 $3,542 - $6,078	127 Added 0.95%	13,452 $551,000
Q1 2020 Apr 21, 2020	BUY	$12.04 - $60.2 $160,433 - $802,165	13,325 New	13,325 $456,000

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $944M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Harvest Investment Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Harvest Investment Services, LLC with notifications on news.